AU5994499A - Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications - Google Patents
Pyridinium derivatives for the treatment of diabetic and aging-related vascular complicationsInfo
- Publication number
- AU5994499A AU5994499A AU59944/99A AU5994499A AU5994499A AU 5994499 A AU5994499 A AU 5994499A AU 59944/99 A AU59944/99 A AU 59944/99A AU 5994499 A AU5994499 A AU 5994499A AU 5994499 A AU5994499 A AU 5994499A
- Authority
- AU
- Australia
- Prior art keywords
- diabetic
- aging
- treatment
- vascular complications
- related vascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN827CA1999 | 1999-10-06 | ||
| IN827CAL99 | 1999-10-06 | ||
| PCT/IB1999/001687 WO2001025209A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5994499A true AU5994499A (en) | 2001-05-10 |
Family
ID=11084921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU59944/99A Abandoned AU5994499A (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1220843A1 (en) |
| JP (1) | JP2003511370A (en) |
| CN (1) | CN1329597A (en) |
| AU (1) | AU5994499A (en) |
| BR (1) | BR9915962A (en) |
| CA (1) | CA2351075A1 (en) |
| CZ (1) | CZ20011808A3 (en) |
| HK (1) | HK1044336A1 (en) |
| HU (1) | HUP0301687A2 (en) |
| MX (1) | MXPA02003496A (en) |
| PL (1) | PL348049A1 (en) |
| WO (1) | WO2001025209A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067851A2 (en) * | 2000-12-29 | 2002-09-06 | Alteon, Inc. | Method for treating fibrotic diseases or other indications iiic |
| CZ303214B6 (en) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridinium compound, process of its preparation, its use, pharmaceutical composition in which it is comprised and use thereof |
| DK1243581T3 (en) * | 2001-03-21 | 2005-10-31 | Torrent Pharmaceuticals Ltd | Pyridinium compounds for the treatment of AGE-related diseases |
| ATE280766T1 (en) * | 2001-04-05 | 2004-11-15 | Torrent Pharmaceuticals Ltd | HETEROCYCLIC COMPOUNDS FOR AGING AND DIABETES-RELATED VASCULAR DISEASES |
| HUP0104831A2 (en) * | 2001-10-19 | 2003-08-28 | Torrent Pharmaceuticals Ltd. | Composition and method for use of pyridinium derivatives in therapeutic applications |
| GB0328314D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Bath | Therapeutics |
| WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
| JP2009155315A (en) * | 2007-12-26 | 2009-07-16 | Fujiyakuhin Co Ltd | Injection product |
| KR20120018185A (en) * | 2009-05-07 | 2012-02-29 | 토렌트 파마슈티칼스 리미티드 | Piperidine derivatives useful for treatment of diebetes |
| JP6621329B2 (en) * | 2012-10-05 | 2019-12-18 | スファエラ ファーマ ピーティーイー リミテッド | Novel compounds, their synthesis and their use |
| CA2997364A1 (en) * | 2015-04-08 | 2016-10-13 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH335521A (en) * | 1955-06-02 | 1959-01-15 | Cilag Ag | Process for the preparation of new quaternary salts |
| US3318787A (en) * | 1964-02-07 | 1967-05-09 | Udylite Corp | Electrodeposition of zinc |
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| JPS5936247B2 (en) * | 1977-04-20 | 1984-09-03 | ティーディーケイ株式会社 | electrical display device |
| JPS55138742A (en) * | 1979-04-17 | 1980-10-29 | Fuji Photo Film Co Ltd | Silver halide emulsion developing method |
| JPH0253759A (en) * | 1988-08-18 | 1990-02-22 | Hamari Yakuhin Kogyo Kk | Novel quaternary ammonium compound |
| DD275872A1 (en) * | 1988-09-27 | 1990-02-07 | Univ Dresden Tech | PROCESS FOR PREPARING 5H-PYRIDO [1 ', 2': 1,2] IMIDAZO [5,4-C] CHINOLIN-6-ONEN |
| EP1327887A3 (en) * | 1995-01-18 | 2008-12-10 | Synvista Therapeutics, Inc. | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products |
| EP0998283A1 (en) * | 1997-04-04 | 2000-05-10 | Smithkline Beecham Corporation | Calcilytic compounds |
-
1999
- 1999-10-15 HU HU0301687A patent/HUP0301687A2/en unknown
- 1999-10-15 WO PCT/IB1999/001687 patent/WO2001025209A1/en not_active Application Discontinuation
- 1999-10-15 CN CN99814055A patent/CN1329597A/en active Pending
- 1999-10-15 BR BR9915962-7A patent/BR9915962A/en not_active IP Right Cessation
- 1999-10-15 CZ CZ20011808A patent/CZ20011808A3/en unknown
- 1999-10-15 PL PL99348049A patent/PL348049A1/en not_active Application Discontinuation
- 1999-10-15 MX MXPA02003496A patent/MXPA02003496A/en unknown
- 1999-10-15 EP EP99974071A patent/EP1220843A1/en not_active Withdrawn
- 1999-10-15 AU AU59944/99A patent/AU5994499A/en not_active Abandoned
- 1999-10-15 CA CA002351075A patent/CA2351075A1/en not_active Abandoned
- 1999-10-15 JP JP2001528155A patent/JP2003511370A/en active Pending
-
2002
- 2002-08-12 HK HK02105890.8A patent/HK1044336A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9915962A (en) | 2003-01-07 |
| WO2001025209A1 (en) | 2001-04-12 |
| CN1329597A (en) | 2002-01-02 |
| PL348049A1 (en) | 2002-05-06 |
| CA2351075A1 (en) | 2001-04-12 |
| MXPA02003496A (en) | 2005-06-20 |
| HUP0301687A2 (en) | 2003-08-28 |
| CZ20011808A3 (en) | 2001-08-15 |
| EP1220843A1 (en) | 2002-07-10 |
| HK1044336A1 (en) | 2002-10-18 |
| JP2003511370A (en) | 2003-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6376300A (en) | Self-occluding catheter | |
| AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
| NO952573D0 (en) | Preparations for the treatment of diabetic complications | |
| AU7373700A (en) | Vascular closure | |
| AU6312199A (en) | Low profile for angioplasty and occlusion catheter | |
| AU1450900A (en) | Methods of treatment of type 2 diabetes | |
| HUP0104116A3 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| AUPQ246799A0 (en) | Surgical screw and guidewire | |
| AU4717301A (en) | Catheter assembly and method of use | |
| AU1585101A (en) | Absorbent article with skin treatment means | |
| AU5238099A (en) | Variable lumen catheter | |
| AU5994499A (en) | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications | |
| AU6157899A (en) | Catheter flush solution and method for its use | |
| AU5240700A (en) | Naphthoquinone derivatives and their use in the treatment and control of tuberculosis | |
| AU2547597A (en) | Double lumen catheter | |
| AU4694999A (en) | Use of thiazolidinedione derivatives for the treatment or prevention of cataracts | |
| AU8758998A (en) | Catheter advancing single-handed soft passer | |
| AU2969597A (en) | Treatment of vascular lesions | |
| AU4770800A (en) | Body treatment product | |
| AU1792901A (en) | Methods for treating and preventing diabetic complications | |
| AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
| AU3119100A (en) | Methods for the prevention and treatment of post-surgical complications | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| AU2420101A (en) | Method and composition for the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |